A year in review: new treatments and expanded indications in dermatology in 2024
Background: There are advances in dermatologic therapies every year. Innovations in new medications transform clinical practice and provide dermatologists new opportunities to enhance patient care.Methods A literature search was conducted on Drugs@FDA: FDA-Approved Drugs for the year 2024 to identif...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2456528 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832583996457877504 |
|---|---|
| author | Lauren N. McGrath Lila G. McGrath John R. Edminister |
| author_facet | Lauren N. McGrath Lila G. McGrath John R. Edminister |
| author_sort | Lauren N. McGrath |
| collection | DOAJ |
| description | Background: There are advances in dermatologic therapies every year. Innovations in new medications transform clinical practice and provide dermatologists new opportunities to enhance patient care.Methods A literature search was conducted on Drugs@FDA: FDA-Approved Drugs for the year 2024 to identify new dermatologic treatments.Results In 2024, the FDA approved seven new dermatologic therapies and expanded the indications for seven current therapies. These therapies treat conditions such as atopic dermatitis, hidradenitis suppurativa, prurigo nodularis, molluscum contagiosum, and alopecia areata, among others. Some of these advancements converge dermatology with rheumatology, gastroenterology, and oncology, which continue to transform therapy for patients with multiple diseases.Conclusion This paper provides a comprehensive overview of these developments and their implications for clinical practice. |
| format | Article |
| id | doaj-art-b0dbab47921047b58296aca899f8677e |
| institution | Kabale University |
| issn | 0954-6634 1471-1753 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Dermatological Treatment |
| spelling | doaj-art-b0dbab47921047b58296aca899f8677e2025-01-28T01:16:56ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532025-12-0136110.1080/09546634.2025.2456528A year in review: new treatments and expanded indications in dermatology in 2024Lauren N. McGrath0Lila G. McGrath1John R. Edminister2Center for Translational Dermatology, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USAWake Forest University School of Medicine, Winston-Salem, North Carolina, USACenter for Translational Dermatology, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USABackground: There are advances in dermatologic therapies every year. Innovations in new medications transform clinical practice and provide dermatologists new opportunities to enhance patient care.Methods A literature search was conducted on Drugs@FDA: FDA-Approved Drugs for the year 2024 to identify new dermatologic treatments.Results In 2024, the FDA approved seven new dermatologic therapies and expanded the indications for seven current therapies. These therapies treat conditions such as atopic dermatitis, hidradenitis suppurativa, prurigo nodularis, molluscum contagiosum, and alopecia areata, among others. Some of these advancements converge dermatology with rheumatology, gastroenterology, and oncology, which continue to transform therapy for patients with multiple diseases.Conclusion This paper provides a comprehensive overview of these developments and their implications for clinical practice.https://www.tandfonline.com/doi/10.1080/09546634.2025.2456528FDA approvalsbiologic therapiesexpanded indicationsimmunotherapytopical therapy |
| spellingShingle | Lauren N. McGrath Lila G. McGrath John R. Edminister A year in review: new treatments and expanded indications in dermatology in 2024 Journal of Dermatological Treatment FDA approvals biologic therapies expanded indications immunotherapy topical therapy |
| title | A year in review: new treatments and expanded indications in dermatology in 2024 |
| title_full | A year in review: new treatments and expanded indications in dermatology in 2024 |
| title_fullStr | A year in review: new treatments and expanded indications in dermatology in 2024 |
| title_full_unstemmed | A year in review: new treatments and expanded indications in dermatology in 2024 |
| title_short | A year in review: new treatments and expanded indications in dermatology in 2024 |
| title_sort | year in review new treatments and expanded indications in dermatology in 2024 |
| topic | FDA approvals biologic therapies expanded indications immunotherapy topical therapy |
| url | https://www.tandfonline.com/doi/10.1080/09546634.2025.2456528 |
| work_keys_str_mv | AT laurennmcgrath ayearinreviewnewtreatmentsandexpandedindicationsindermatologyin2024 AT lilagmcgrath ayearinreviewnewtreatmentsandexpandedindicationsindermatologyin2024 AT johnredminister ayearinreviewnewtreatmentsandexpandedindicationsindermatologyin2024 AT laurennmcgrath yearinreviewnewtreatmentsandexpandedindicationsindermatologyin2024 AT lilagmcgrath yearinreviewnewtreatmentsandexpandedindicationsindermatologyin2024 AT johnredminister yearinreviewnewtreatmentsandexpandedindicationsindermatologyin2024 |